CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,428,677 | +181024.0% | 89,242 | +9.1% | 0.00% | +100.0% |
| Q1 2023 | $1,893 | -10.9% | 81,771 | +0.8% | 0.00% | -33.3% |
| Q4 2022 | $2,125 | -99.9% | 81,093 | +5.7% | 0.00% | +50.0% |
| Q3 2022 | $1,508,000 | +36.0% | 76,711 | +21.0% | 0.00% | 0.0% |
| Q2 2022 | $1,109,000 | +35.1% | 63,397 | +26.3% | 0.00% | +100.0% |
| Q1 2022 | $821,000 | +9.9% | 50,184 | +9.5% | 0.00% | 0.0% |
| Q4 2021 | $747,000 | +42.6% | 45,822 | +11.5% | 0.00% | 0.0% |
| Q3 2021 | $524,000 | -5.8% | 41,083 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $556,000 | +123.3% | 39,388 | +145.4% | 0.00% | – |
| Q1 2021 | $249,000 | -6.7% | 16,048 | -4.6% | 0.00% | – |
| Q4 2020 | $267,000 | – | 16,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |